Details of the Drug

General Information of Drug (ID: DMWB310)

Drug Name

Satralizumab

Indication

Disease Entry	ICD 11	Status	REF
Neuromyelitis optica spectrum disorder	8E4A.0	Approved	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020